Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Part of paid clinical trials in Quincy, Massachusetts.

Sponsor
Endogenex, Inc.
Study ID
NCT07197775
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.

Key Dates

Start date
Mar 11, 2026
Status verified
Jun 2026
Primary completion
May 31, 2032
Completion
May 31, 2032

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Endogenex System Treated
    Participants treated with the Endogenex System

Primary Outcome Measure

Incidence of adverse events [ Time Frame: Through 5 years ]

Locations (3)

FacilityCityStateZIPSite coordinators
Care AccessQuincyMassachusetts02169-
Care AccessRaleighNorth Carolina27607-
Care AccessHoustonTexas77054-

Find similar trials in Quincy, MA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Care Access· Quincy, MACare Access· Raleigh, NCCare Access· Houston, TX

Related Studies